Invitation for a Perspective/Review Article for New Journal of Chemistry “Application of Site-Identification by Ligand Competitive Saturation in Computer-Aided Drug Design”
SilcsBio Spinout Raises $1.5 Million Investment
FOR IMMEDIATE RELEASE: SilcsBio Spinout Raises $1.5 Million to Advance Drug Development New investment from Bluedot Bio into Rasio follows initial funding from the National Foundation for Cancer Research December 2, 2021, Baltimore, MD – Rasio Therapeutics, a joint venture formed by SilcsBio and the National Foundation for Cancer Research (NFCR) to develop […]
SilcsBio Announces Hiring of KC Song as Full Stack Developer
Song will focus on web applications development and solutions to help drive SilcsBio’s continued growth September 28, 2021, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of KC Song as Full Stack Developer. Song joins the SilcsBio team as an experienced […]
SilcsBio Announces Hiring of Ankita Katiyar, PhD as Application Scientist
Katiyar will focus on fueling product and technology development for SilcsBio August 24, 2021, Baltimore, MD – – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced the hiring of Ankita Katiyar, PhD as Applications Scientist focusing on product development. Katiyar – a chemist with expertise in […]
SilcsBio Awarded $1,760,531 in SBIR Phase II Funding from the National Institutes of Health
SilcsBio will leverage the award to extend its commercially available software from small molecule design to the design of biological therapeutics November 16, 2021, Baltimore, MD – SilcsBio, a technology company that develops and markets software and services for structure-based drug design, today announced it has been awarded a $1,760,531 Small Business Innovation Research (SBIR) Phase […]
Aikido Provides Update on Use of Machine Learning in Drug Development Program
FOR IMMEDIATE RELEASE: Aikido Provides Update on Use of Machine Learning in Drug Development Program NEW YORK, NY August , 2021 /PRNewswire/ AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today provided and update on the use of Machine Learning in support of its antiviral platform with the University of Maryland Baltimore School of […]
Job Opening: Scientific Programmer
SilcsBio’s parent company, Early Charm, has a job opening to work with SilcsBio and other companies in its Drug Design Portfolio. Immediate Job Opening Scientific Programmer July 27, 2021 What we do: Early Charm creates, owns, and operates businesses that convert science into revenue. We are the management team, the operators, […]